Due to the COVID-19 Corona virus pandemic, the European Society for Translational Medicine (EUSTM) has revised this year’s congress format to a virtual event. EUSTM took this initiative to ensure the health and safety of our global delegates. The congress will address & discuss current COVID-19 pandemic challenges and solutions. This Virtual Congress will focus on the key principles of Translational Medicine: Bench side, Bed side and Public Health.
EUSTM-2020 represent a unique multidisciplinary virtual platform where high profile benchside researchers, clinicians, industry professionals and public health professionals will discuss and address current challenges, highlight novel solutions, latest endings and identify critical hurdles as they apply to COVID-19
EUSTM-2020 represents a unique opportunity to acquire current information that is essential for the continued worldwide effort to limit coronavirus infections and treat the multiple aspects of COVID-19, all while providing global networking opportunities with key opinion leaders and service providers.
The congress will be virtual in nature and will highlight high profile presentations (pre-recorded) and E-posters by the global multidisciplinary experts from 21-25 September, 2020. The congress will be hosted at the virtual platform. The delegates will have access to latest developments and updates by the industry and vendors.
EUSTM-2020 cordially invites industry partners actively engaged on any aspect of Corona virology/COVID-19 to apply for the below sponsorship and exhibition opportunities. Due to virtual congress, the following slots would proivde great opportunity to showcase services/products to global multidisciplinary audience. Following types of opportunities are available on ‘first–come, first–served basis.
